Vismodegib and Enzalutamide Recommended for EU ApprovalVismodegib and Enzalutamide Recommended for EU Approval

In addition, 2 generic cancer drugs have been recommended for approval in Europe: the oral agents capecitabine and imatinib. International Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news